EMAIL THIS PAGE TO A FRIEND

Journal of immunology (Baltimore, Md. : 1950)

Imipramine exploits histone deacetylase 11 to increase the IL-12/IL-10 ratio in macrophages infected with antimony-resistant Leishmania donovani and clears organ parasites in experimental infection.


PMID 25217162

Abstract

The efflux of antimony through multidrug resistance protein (MDR)-1 is the key factor in the failure of metalloid treatment in kala-azar patients infected with antimony-resistant Leishmania donovani (Sb(R)LD). Previously we showed that MDR-1 upregulation in Sb(R)LD infection is IL-10-dependent. Imipramine, a drug in use for the treatment of depression and nocturnal enuresis in children, inhibits IL-10 production from Sb(R)LD-infected macrophages (Sb(R)LD-Mϕs) and favors accumulation of surrogates of antimonials. It inhibits IL-10-driven nuclear translocation of c-Fos/c-Jun, critical for enhanced MDR-1 expression. The drug upregulates histone deacetylase 11, which inhibits acetylation of IL-10 promoter, leading to a decrease in IL-10 production from Sb(R)LD-Mϕs. It abrogates Sb(R)LD-mediated p50/c-Rel binding to IL-10 promoter and preferentially recruits p65/RelB to IL-12 p35 and p40 promoters, causing a decrease in IL-10 and overproduction of IL-12 in Sb(R)LD-Mϕs. Histone deacetylase 11 per se does not influence IL-12 promoter activity. Instead, a imipramine-mediated decreased IL-10 level allows optimal IL-12 production in Sb(R)LD-Mϕs. Furthermore, exogenous rIL-12 inhibits intracellular Sb(R)LD replication, which can be mimicked by the presence of Ab to IL-10. This observation indicated that reciprocity exists between IL-10 and IL-12 and that imipramine tips the balance toward an increased IL-12/IL-10 ratio in Sb(R)LD-Mϕs. Oral treatment of infected BALB/c mice with imipramine in combination with sodium stibogluconate cleared organ Sb(R)LD parasites and caused an expansion of the antileishmanial T cell repertoire where sodium stibogluconate alone had no effect. Our study deciphers a detailed molecular mechanism of imipramine-mediated regulation of IL-10/IL-12 reciprocity and its impact on Sb(R)LD clearance from infected hosts.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

CKOZFN1749 CompoZr® Knockout ZFN Kit, Human IL10 (NM_000572)
CKOZFND1749 CompoZr® Knockout ZFN Kit, ZFN plasmid only, Human IL10 (NM_000572)
RAB0244
Human IL-10 ELISA Kit, for serum, plasma, cell culture supernatant and urine
RAB0249
Human IL-10 R β ELISA Kit, for serum, plasma, cell culture supernatant and urine
SRP3312 IL-10 human, Animal-component free, recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC)
SRP3071 IL-10 human, recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
Y0000893
Imipramine for system suitability, European Pharmacopoeia (EP) Reference Standard
C19H24N2 · HCl
I0899
Imipramine hydrochloride, BioXtra, ≥99% (TLC)
C19H24N2 · HCl
I0100000
Imipramine hydrochloride, European Pharmacopoeia (EP) Reference Standard
C19H24N2 · HCl
1338007
Imipramine hydrochloride, United States Pharmacopeia (USP) Reference Standard
C19H24N2 · HCl
I7379
Imipramine hydrochloride, ≥99% (TLC)
C19H24N2 · HCl
I-902
Imipramine hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material
C19H24N2 · HCl
I9276 Interleukin-10 human, ≥97% (SDS-PAGE), recombinant, expressed in baculovirus infected Sf21 cells, lyophilized powder, cell culture tested
H7541 Interleukin-10 human, IL-10, recombinant, expressed in HEK 293 cells, HumanKine®, suitable for cell culture
EHU086221 MISSION® esiRNA, esiRNA human TGIF (esiRNA1)
EHU145171 MISSION® esiRNA, esiRNA human IL10 (esiRNA1)